BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 8533550)

  • 1. Effect of neostigmine at different levels of mivacurium-induced neuromuscular blockade.
    Trévien V; Lienhart A; Just B; Chandon M; Baras E; Camatte S
    Acta Anaesthesiol Scand Suppl; 1995; 106():66-9. PubMed ID: 8533550
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recovery from mivacurium block with or without anticholinesterase following continuous infusion in obstetric patients.
    Jan GS; Tong WN; Chan AM; Hui TW; Lo JW
    Anaesth Intensive Care; 1996 Oct; 24(5):585-9. PubMed ID: 8909671
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A comparison of the neuromuscular blocking effects of atracurium, mivacurium, and vecuronium on the adductor pollicis and the orbicularis oculi muscle in humans.
    Rimaniol JM; Dhonneur G; Sperry L; Duvaldestin P
    Anesth Analg; 1996 Oct; 83(4):808-13. PubMed ID: 8831326
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Perioperative train-of-four monitoring and residual curarization.
    Shorten GD; Merk H; Sieber T
    Can J Anaesth; 1995 Aug; 42(8):711-5. PubMed ID: 7586111
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enzymatic versus pharmacologic antagonism of profound mivacurium- induced neuromuscular blockade.
    Naguib M; Selim M; Bakhamees HS; Samarkandi AH; Turkistani A
    Anesthesiology; 1996 May; 84(5):1051-9. PubMed ID: 8623998
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Factors predicting atracurium reversal time.
    Kirkegaard-Nielsen H; Severinsen IK; Pedersen HS; Lindholm P
    Acta Anaesthesiol Scand; 1999 Sep; 43(8):834-41. PubMed ID: 10492412
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antagonism of atracurium-induced block in obese patients.
    Kirkegaard-Nielsen H; Lindholm P; Petersen HS; Severinsen IK
    Can J Anaesth; 1998 Jan; 45(1):39-41. PubMed ID: 9466025
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Neostigmine and edrophonium. Antagonism of profound and shallow mivacurium blockade].
    Bartunek A; Gilly H; Huemer G; Yildiz S; Schramm W; Lackner FX; Foldes FF
    Anaesthesist; 1997 Feb; 46(2):96-100. PubMed ID: 9133184
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of rocuronium and mivacurium to succinylcholine during outpatient laparoscopic surgery.
    Tang J; Joshi GP; White PF
    Anesth Analg; 1996 May; 82(5):994-8. PubMed ID: 8610912
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dose responses for neostigmine and edrophonium as antagonists of mivacurium in adults and children.
    Bevan JC; Tousignant C; Stephenson C; Blackman L; Reimer E; Smith MF; Bevan DR
    Anesthesiology; 1996 Feb; 84(2):354-61. PubMed ID: 8602666
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Blood flow and mivacurium-induced neuromuscular block at the orbicularis oculi and adductor pollicis muscles.
    Abdulatif M; el-Sanabary M
    Br J Anaesth; 1997 Jul; 79(1):24-8. PubMed ID: 9301384
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dose-response relationships for edrophonium and neostigmine antagonism of mivacurium-induced neuromuscular block.
    Naguib M; Abdulatif M; al-Ghamdi A; Hamo I; Nouheid R
    Br J Anaesth; 1993 Nov; 71(5):709-14. PubMed ID: 8251285
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enzymatic antagonism of mivacurium-induced neuromuscular blockade by human plasma cholinesterase.
    Naguib M; Daoud W; el-Gammal M; Ammar A; Turkistani A; Selim M; Altamimi W; Sohaibani MO
    Anesthesiology; 1995 Oct; 83(4):694-701. PubMed ID: 7574048
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Spontaneous versus edrophonium-induced recovery from paralysis with mivacurium.
    Brandom BW; Taiwo OO; Woelfel SK; Schön H; Gronert BJ; Cook DR
    Anesth Analg; 1996 May; 82(5):999-1002. PubMed ID: 8610913
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Optimum time for neostigmine administration to antagonize vecuronium-induced neuromuscular blockade.
    Kirkegaard-Nielsen H; Toft P; Severinsen IK; May O
    Eur J Anaesthesiol; 1995 Nov; 12(6):585-9. PubMed ID: 8665881
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recovery characteristics after early administration of anticholinesterases during intense mivacurium-induced neuromuscular block.
    Abdulatif M
    Br J Anaesth; 1995 Jan; 74(1):20-5. PubMed ID: 7880699
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reversal of doxacurium and pancuronium neuromuscular blockade with neostigmine in children.
    Bevan JC; Purday JP; Reimer EJ; Bevan DR
    Can J Anaesth; 1994 Nov; 41(11):1074-80. PubMed ID: 7828255
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of neostigmine-induced recovery with spontaneous recovery from mivacurium-induced neuromuscular block.
    Baurain MJ; Dernovoi BS; d'Hollander AA; Hennart DA
    Br J Anaesth; 1994 Dec; 73(6):791-4. PubMed ID: 7880668
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Effect of halothane, enflurane and isoflurane on the pharmacodynamics of mivacurium in children].
    Neidhart G; Pabelick C; Kuhn I; Leuwer M; Vettermann J
    Anasthesiol Intensivmed Notfallmed Schmerzther; 1996 Jun; 31(5):293-7. PubMed ID: 8767242
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neuromuscular and clinical effects of mivacurium chloride in healthy adult patients during nitrous oxide-enflurane anaesthesia.
    Goldhill DR; Whitehead JP; Emmott RS; Griffith AP; Bracey BJ; Flynn PJ
    Br J Anaesth; 1991 Sep; 67(3):289-95. PubMed ID: 1832920
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.